Plus   Neg

Vertex Pharmaceuticals Inc. Q2 adjusted earnings Beat Estimates

Vertex Pharmaceuticals Inc. (VRTX) reported earnings for its second quarter that increased from last year.

The company's profit came in at $267 million, or $1.03 per share. This compares with $207 million, or $0.80 per share, in last year's second quarter.

Excluding items, Vertex Pharmaceuticals Inc. reported adjusted earnings of $327 million or $1.26 per share for the period.

Analysts had expected the company to earn $1.07 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter rose 25.1% to $941.29 million from $752.16 million last year.

Vertex Pharmaceuticals Inc. earnings at a glance:

-Earnings (Q2): $327 Mln. vs. $244 Mln. last year.
-EPS (Q2): $1.26 vs. $0.94 last year.
-Analysts Estimate: $1.07
-Revenue (Q2): $941.29 Mln vs. $752.16 Mln last year.

Full year revenue guidance: $3.60 to $3.70 Bln

For comments and feedback contact: editorial@rttnews.com

Follow RTT